Primecap Management’s Abiomed Inc ABMD Stock Holding History

Primecap Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,506,272	Closed	-$370M	–	342
2022 Q3	$370M	Sell	1,506,272 -32,980	-2%	-$8.91M	0.36%	68
2022 Q2	$381M	Sell	1,539,252 -71,360	-4%	-$19.3M	0.34%	69
2022 Q1	$533M	Sell	1,610,612 -57,020	-3%	-$17.6M	0.4%	67
2021 Q4	$599M	Sell	1,667,632 -132,860	-7%	-$44.9M	0.41%	66
2021 Q3	$586M	Sell	1,800,492 -56,300	-3%	-$19.1M	0.41%	67
2021 Q2	$580M	Sell	1,856,792 -61,280	-3%	-$18.8M	0.39%	69
2021 Q1	$611M	Sell	1,918,072 -129,790	-6%	-$41.5M	0.43%	65
2020 Q4	$664M	Sell	2,047,862 -175,980	-8%	-$48.7M	0.49%	59
2020 Q3	$616M	Sell	2,223,842 -418,970	-16%	-$121M	0.51%	53
2020 Q2	$638M	Sell	2,642,812 -281,530	-10%	-$56.5M	0.55%	50
2020 Q1	$424M	Sell	2,924,342 -158,498	-5%	-$26.3M	0.42%	60
2019 Q4	$526M	Sell	3,082,840 -3,000	-0.1%	-$556K	0.38%	63
2019 Q3	$549M	Sell	3,085,840 -45,200	-1%	-$9.77M	0.44%	61
2019 Q2	$816M	Sell	3,131,040 -18,000	-0.6%	-$4.78M	0.6%	54
2019 Q1	$899M	Sell	3,149,040 -81,200	-3%	-$27M	0.66%	48
2018 Q4	$1.05B	Sell	3,230,240 -141,700	-4%	-$49.2M	0.85%	37
2018 Q3	$1.52B	Sell	3,371,940 -190,000	-5%	-$74.9M	1.02%	31
2018 Q2	$1.46B	Sell	3,561,940 -260,750	-7%	-$94.5M	1.08%	25
2018 Q1	$1.11B	Sell	3,822,690 -256,700	-6%	-$65.1M	0.83%	39
2017 Q4	$765M	Sell	4,079,390 -138,500	-3%	-$25.9M	0.59%	53
2017 Q3	$711M	Sell	4,217,890 -216,198	-5%	-$32.7M	0.59%	50
2017 Q2	$635M	Sell	4,434,088 -202,502	-4%	-$27.2M	0.55%	52
2017 Q1	$581M	Sell	4,636,590 -40,040	-0.9%	-$4.64M	0.53%	53
2016 Q4	$527M	Sell	4,676,630 -31,960	-0.7%	-$3.7M	0.52%	54
2016 Q3	$605M	Sell	4,708,590 -297,900	-6%	-$35.7M	0.6%	48
2016 Q2	$547M	Sell	5,006,490 -528,800	-10%	-$52.6M	0.58%	50
2016 Q1	$525M	Sell	5,535,290 -121,800	-2%	-$10.3M	0.54%	54
2015 Q4	$511M	Sell	5,657,090 -11,000	-0.2%	-$934K	0.52%	57
2015 Q3	$526M	Hold	5,668,090	–	–	0.58%	52
2015 Q2	$373M	Buy	5,668,090 +5,500	+0.1%	+$365K	0.37%	69
2015 Q1	$405M	Sell	5,662,590 -25,000	-0.4%	-$1.36M	0.4%	64
2014 Q4	$216M	Buy	5,687,590 +22,600	+0.4%	+$713K	0.22%	92
2014 Q3	$141M	Sell	5,664,990 -61,500	-1%	-$1.56M	0.15%	103
2014 Q2	$144M	Sell	5,726,490 -25,500	-0.4%	-$594K	0.16%	105
2014 Q1	$150M	Hold	5,751,990	–	–	0.17%	100
2013 Q4	$154M	Hold	5,751,990	–	–	0.18%	98
2013 Q3	$110M	Hold	5,751,990	–	–	0.14%	107
2013 Q2	$124M	Buy	+5,751,990	New	+$116M	0.18%	95

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Primecap Management's ABMD Position: Q4 2022 in Review

Primecap Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,506,272 shares — an estimated $370M sold.

Primecap Management first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $1.52B in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Primecap Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Primecap Management sold 1,506,272 Abiomed Inc shares in Q4 2022, an estimated $370M.
Primecap Management first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Primecap Management's Abiomed Inc position peaked at $1.52B in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.